LONDON (REUTERS) – On Monday (November 5th), health professionals said about 33,000 people were killed in Europe each year in Europe, comparable to flu, tuberculosis and HIV.
An analysis by the European Center for Disease Prevention and Control (ECDC) has shown that the effects of drug-resistant infections have increased since 2007, and even when the damage is resistant to even the most potent recent treatment antibiotics, including the class of medicines known as carbapenems.
"This … is alarming, because these antibiotics are the latest available treatment options," the ECDC said.
"If they are no longer effective, it is very difficult or in many cases impossible to treat the infection."
Experts estimate that about 70% of bacteria that can cause infection are already resistant to at least one antibiotic that is commonly used to treat them.
This has led to the development of "superbugs" that can avoid the use of one or more drugs, one of the greatest threats today facing medicine.
The ECDC study published in the Lancet Infectious Disease Journal focused on five types of infections caused by antibiotic-resistant bacteria in the European Union and the European Economic Area (EU / EEA).
About 75 percent of the burden of superbug disease was found to be infectious in hospitals and healthcare clinics called health-care infections (HAIs).
"Strategies for the prevention and control of antibiotic-resistant bacteria require coordination in the EU, the EEA and globally," he said. It added that differences between countries and antibiotic-resistant bacteria that cause infection in different countries, prevention and control measures should be adapted to national situations.